Therapeutics News and Research

RSS
Phase 1 clinical trial of new anticancer drug from Human Genome Sciences

Phase 1 clinical trial of new anticancer drug from Human Genome Sciences

Researchers using light to control genes and better understand the role of certain genes in embryonic development

Researchers using light to control genes and better understand the role of certain genes in embryonic development

Research could lead to ways to prevent arrhythmias

Research could lead to ways to prevent arrhythmias

Embryonic stem cell therapy show benefits in rebuilding damaged heart

Embryonic stem cell therapy show benefits in rebuilding damaged heart

Study on RNAi technology targeting neurodegenerative diseases

Study on RNAi technology targeting neurodegenerative diseases

Finnish company discovers over 200 new genes

Finnish company discovers over 200 new genes

Important for physicians to identify patients at risk for hyperkalemia and implement corresponding measures when using ACE inhibitors

Important for physicians to identify patients at risk for hyperkalemia and implement corresponding measures when using ACE inhibitors

Free licences of European patents on the hereditary breast cancer gene BRCA2

Free licences of European patents on the hereditary breast cancer gene BRCA2

Bionomics BNO69 angiogenesis gene discovery published

Bionomics BNO69 angiogenesis gene discovery published

Total global market for oligonucleotides is likely to grow from USD 340.0 million in 2003 to USD 776.0 million in 2010

Total global market for oligonucleotides is likely to grow from USD 340.0 million in 2003 to USD 776.0 million in 2010

CV Therapeutics initiates approval-enabling trial of drug to treat chronic angina

CV Therapeutics initiates approval-enabling trial of drug to treat chronic angina

Metabasis Therapeutics announces multi-center Phase 2 study to evaluate the orally administered antiviral compound remofovir mesylate

Metabasis Therapeutics announces multi-center Phase 2 study to evaluate the orally administered antiviral compound remofovir mesylate

Recommendation against the use of chemotherapy sensitivity and resistance assays

Recommendation against the use of chemotherapy sensitivity and resistance assays

Identification of PIK3CA as an oncogene associated with brain cancers opens the door to new screening processes

Identification of PIK3CA as an oncogene associated with brain cancers opens the door to new screening processes

New process that simplifies the production of proteins

New process that simplifies the production of proteins

Y's Therapeutics files for clinical trials in Europe for rheumatoid arthritis and asthma

Y's Therapeutics files for clinical trials in Europe for rheumatoid arthritis and asthma

New DNA microarray to speed bone disease research

New DNA microarray to speed bone disease research

Cancer Research Technology grants exclusive license to Genentech to patent portfolio of an oncology target

Cancer Research Technology grants exclusive license to Genentech to patent portfolio of an oncology target

3M and MicroDose Technologies Inc. team up to bring advanced electronic dry powder inhaler to market

3M and MicroDose Technologies Inc. team up to bring advanced electronic dry powder inhaler to market

Market research 'World RNAi Markets: Current and Future Outlook'

Market research 'World RNAi Markets: Current and Future Outlook'

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.